The American Kidnal fund, one of the two largest indexes of U.S. funds, is set to receive a $2.9 billion infusion from Vanguard in 2018.
The fund will be able to use funds in Vanguard’s portfolio to buy stocks that outperform the index fund and is expected to have a large impact on stocks in the broader market.
The American kidney fund was set up in 2008 and manages $2 billion in assets under the management of its CEO and Chief Investment Officer.
It was founded by a group of wealthy philanthropists.
This article was originally published on Ars Technic.